These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1027 related articles for article (PubMed ID: 18319412)
1. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW; JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433 [TBL] [Abstract][Full Text] [Related]
3. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742 [TBL] [Abstract][Full Text] [Related]
4. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas. Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097 [TBL] [Abstract][Full Text] [Related]
5. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Regine WF; Winter KA; Abrams R; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Rich TA; Willett CG Ann Surg Oncol; 2011 May; 18(5):1319-26. PubMed ID: 21499862 [TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW; JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Oettle H; Post S; Neuhaus P; Gellert K; Langrehr J; Ridwelski K; Schramm H; Fahlke J; Zuelke C; Burkart C; Gutberlet K; Kettner E; Schmalenberg H; Weigang-Koehler K; Bechstein WO; Niedergethmann M; Schmidt-Wolf I; Roll L; Doerken B; Riess H JAMA; 2007 Jan; 297(3):267-77. PubMed ID: 17227978 [TBL] [Abstract][Full Text] [Related]
8. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V; Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442 [TBL] [Abstract][Full Text] [Related]
9. Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial. Bachet JB; Hammel P; Desramé J; Meurisse A; Chibaudel B; André T; Debourdeau P; Dauba J; Lecomte T; Seitz JF; Tournigand C; Aparicio T; Meyer VG; Taieb J; Volet J; Monier A; Bonnetain F; Louvet C Lancet Gastroenterol Hepatol; 2017 May; 2(5):337-346. PubMed ID: 28397697 [TBL] [Abstract][Full Text] [Related]
10. [Chemoradiation for pancreatic adenocarcinoma]. Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252 [TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study. Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132 [TBL] [Abstract][Full Text] [Related]
12. Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens. Kizilbash SH; Ward KC; Liang JJ; Jaiyesimi I; Lipscomb J Int J Clin Pract; 2014 May; 68(5):578-89. PubMed ID: 24472057 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. Landry J; Catalano PJ; Staley C; Harris W; Hoffman J; Talamonti M; Xu N; Cooper H; Benson AB J Surg Oncol; 2010 Jun; 101(7):587-92. PubMed ID: 20461765 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. Oettle H; Neuhaus P; Hochhaus A; Hartmann JT; Gellert K; Ridwelski K; Niedergethmann M; Zülke C; Fahlke J; Arning MB; Sinn M; Hinke A; Riess H JAMA; 2013 Oct; 310(14):1473-81. PubMed ID: 24104372 [TBL] [Abstract][Full Text] [Related]
15. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. Ammori JB; Colletti LM; Zalupski MM; Eckhauser FE; Greenson JK; Dimick J; Lawrence TS; McGinn CJ J Gastrointest Surg; 2003; 7(6):766-72. PubMed ID: 13129554 [TBL] [Abstract][Full Text] [Related]
16. Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. Kornek GV; Pötter R; Selzer E; Schratter A; Ulrich-Pur H; Rogy M; Kraus G; Scheithauer W Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):665-71. PubMed ID: 11172947 [TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer. Wilkowski R; Thoma M; Bruns C; Wagner A; Heinemann V JOP; 2006 Jul; 7(4):349-60. PubMed ID: 16832132 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical factors and treatment results in patients with advanced pancreatic cancer. Brasiūnas V; Brasiūniene B; Juozaityte E; Barauskas G Medicina (Kaunas); 2004; 40(11):1074-80. PubMed ID: 15547308 [TBL] [Abstract][Full Text] [Related]
19. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Blackstock AW; Tepper JE; Niedwiecki D; Hollis DR; Mayer RJ; Tempero MA Int J Gastrointest Cancer; 2003; 34(2-3):107-16. PubMed ID: 15361643 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study. Garnier J; Ewald J; Marchese U; Gilabert M; Launay S; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O BMC Cancer; 2020 Mar; 20(1):203. PubMed ID: 32164564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]